CD274 and neoplasm: As for the programmed death ligand 1 (PD-L1), it has been validated that the administration of anti-PD-L1 contributes to dampening the growth of tumor cells in normal syngeneic mice, suggesting that the PD-L1 serves as an effective modulator for potentially immunogenic tumors to escape from the host immune responses [19].